Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFERIPRONE vs DEFLAZACORT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFERIPRONE vs DEFLAZACORT: Safety Overview

Metric DEFERIPRONE DEFLAZACORT
Total FAERS Reports 2,487 3,831
Deaths Reported 287 149
Death Rate 11.5% 3.9%
Hospitalizations 923 592
Average Patient Age 41.7 yrs 25.7 yrs
% Female Patients 57.4% 15.1%
FDA Approval Date Apr 20, 2018 Apr 25, 2024
Manufacturer Chiesi USA, Inc. Cranbury Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription